3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one

C14H28N2O2 — CID 83243563

IUPAC3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
SMILESCOCCCN1C(=O)C(CC(C)C)NC1C(C)C
InChIInChI=1S/C14H28N2O2/c1-10(2)9-12-14(17)16(7-6-8-18-5)13(15-12)11(3)4/h10-13,15H,6-9H2,1-5H3
InChIKeyDIKJJCFEKHDDPH-UHFFFAOYSA-N
MW256.39 g/mol
LogP1.85
Rot. Bonds7

About 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one

3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one (PubChem CID 83243563) has the molecular formula C14H28N2O2 and a molecular weight of 256.39 g/mol. Its IUPAC name is 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one.

Molecular Properties

Compound Name3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
PubChem CID83243563
Molecular FormulaC14H28N2O2
Molecular Weight256.39 g/mol
Exact Mass256.22
IUPAC Name3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
SMILESCOCCCN1C(=O)C(CC(C)C)NC1C(C)C
InChIInChI=1S/C14H28N2O2/c1-10(2)9-12-14(17)16(7-6-8-18-5)13(15-12)11(3)4/h10-13,15H,6-9H2,1-5H3
InChIKeyDIKJJCFEKHDDPH-UHFFFAOYSA-N
XLogP1.85
TPSA41.57 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500256.39
LogP ≤ 51.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-ethyl-3-(4-methoxybutyl)-2-propan-2-ylimidazolidin-4-one
CID 83245585
5-(2-methylpropyl)-3-(2-methylsulfinylethyl)-2-propan-2-ylimidazolidin-4-one
CID 113480746
3-(3-methoxypropyl)-2-(2-methylpropyl)-5-propylimidazolidin-4-one
CID 83243478
6-tert-butyl-1-(3-methoxypropyl)-3-(2-methylpropyl)piperazine-2,5-dione
CID 64902495
3-(3-methoxypropyl)-5-phenyl-2-propan-2-ylimidazolidin-4-one
CID 83243404
3-[(2-methylcyclopropyl)methyl]-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 113464309
2-ethyl-5-(2-methylpropyl)-3-(3-propoxypropyl)imidazolidin-4-one
CID 83260824
2-methyl-3-(4-methylpentyl)-5-(2-methylpropyl)imidazolidin-4-one
CID 83254538
3-(4-methylpentyl)-2,5-bis(2-methylpropyl)imidazolidin-4-one
CID 83254863
3-(3-methoxy-2-methylpropyl)-2-methyl-5-(2-methylpropyl)imidazolidin-4-one
CID 83250020
5-butyl-2-propan-2-yl-3-(2-propan-2-yloxyethyl)imidazolidin-4-one
CID 104767679
3-[(3-methoxyoxolan-3-yl)methyl]-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one
CID 104767840

Frequently Asked Questions

What is the IUPAC name of 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The IUPAC name of 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one (CID 83243563) is 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one.
What is the SMILES notation for 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The canonical SMILES for 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one is COCCCN1C(=O)C(CC(C)C)NC1C(C)C.
What is the InChIKey of 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
The InChIKey is DIKJJCFEKHDDPH-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H28N2O2/c1-10(2)9-12-14(17)16(7-6-8-18-5)13(15-12)11(3)4/h10-13,15H,6-9H2,1-5H3.
What are the key properties of 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one?
3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one has a molecular weight of 256.39 g/mol, XLogP of 1.85, 7 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3-methoxypropyl)-5-(2-methylpropyl)-2-propan-2-ylimidazolidin-4-one is sourced from PubChem (CID 83243563), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).